Eyenovia, Inc. (EYEN)
Largest Insider Buys in Sector
EYEN Stock Price History Chart
EYEN Stock Performance
About Eyenovia, Inc.
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the development of therapeutic indications for patients with progressive myopia and age-related near vision impairment or presbyopia indications; and microdose fixed combination ophthalmic pharmaceutical for mydriasis to address the eye exams with pupil dilation. The company's product candidates include MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); and MydCombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; and a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine and MicroLine in China and South Korea. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York.
Insider Activity of Eyenovia, Inc.
Over the last 12 months, insiders at Eyenovia, Inc. have bought $337,388 and sold $0 worth of Eyenovia, Inc. stock.
On average, over the past 5 years, insiders at Eyenovia, Inc. have bought $3.3M and sold $1.27M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Grant Stuart M. (10 percent owner) — $318,326. Strahlman Ellen R (director) — $24,293. Rowe Michael M (Chief Executive Officer) — $10,964.
The last purchase of 100,000 shares for transaction amount of $98,000 was made by Grant Stuart M. (10 percent owner) on 2024‑03‑28.
List of Insider Buy and Sell Transactions, Eyenovia, Inc.
| 2024-03-28 | Grant Stuart M. | 10 percent owner | 100,000 0.2097% | $0.98 | $98,000 | -25.95% | ||
| 2024-03-19 | Grant Stuart M. | 10 percent owner | 50,000 0.1186% | $1.23 | $61,500 | -37.53% | ||
| 2024-03-08 | Grant Stuart M. | 10 percent owner | 10,717 0.0243% | $1.58 | $16,911 | -52.44% | ||
| 2023-12-04 | Rowe Michael M | Chief Executive Officer | 4,890 0.011% | $1.36 | $6,650 | -2.17% | ||
| 2023-09-29 | Strahlman Ellen R | director | 4,820 0.0128% | $1.68 | $8,098 | -18.37% | ||
| 2023-09-19 | Rowe Michael M | Chief Executive Officer | 1,400 0.0036% | $1.66 | $2,324 | -18.05% | ||
| 2023-09-15 | Rowe Michael M | Chief Executive Officer | 1,137 0.003% | $1.75 | $1,990 | -19.83% | ||
| 2023-08-17 | Grant Stuart M. | 10 percent owner | 30,000 0.082% | $1.87 | $56,100 | -19.40% | ||
| 2023-08-16 | Grant Stuart M. | 10 percent owner | 45,000 0.1195% | $1.91 | $85,815 | -21.69% | ||
| 2023-05-31 | GANDOLFO JOHN P | Chief Financial Officer | 2,000 0.0053% | $2.79 | $5,580 | -41.02% | ||
| 2023-05-26 | MATHER CHARLES E IV | director | 3,000 0.0077% | $2.49 | $7,470 | -34.75% | ||
| 2023-05-26 | Kern Bren | Chief Operating Officer | 2,500 0.007% | $2.73 | $6,825 | -34.75% | ||
| 2023-05-25 | Grant Stuart M. | 10 percent owner | 88,247 0.2531% | $2.65 | $233,855 | -31.38% | ||
| 2023-05-23 | Strahlman Ellen R | director | 10,000 0.027% | $3.10 | $30,976 | -44.63% | ||
| 2023-05-15 | MATHER CHARLES E IV | director | 4,000 0.011% | $3.39 | $13,560 | -47.80% | ||
| 2023-05-01 | Sale | Ianchulev Tsontcho | director | 90,000 0.2501% | $5.50 | $495,000 | -66.65% | |
| 2023-04-27 | Sale | Ianchulev Tsontcho | director | 60,000 0.1604% | $5.00 | $300,000 | -64.60% | |
| 2023-04-14 | Sale | Ianchulev Tsontcho | director | 40,000 0.1035% | $4.50 | $180,000 | -60.75% | |
| 2023-04-11 | Sale | Ianchulev Tsontcho | director | 40,000 0.1048% | $4.00 | $160,000 | -55.15% | |
| 2023-03-31 | Sale | Ianchulev Tsontcho | director | 40,000 0.106% | $3.50 | $140,000 | -47.73% |
Insider Historical Profitability
| Grant Stuart M. | 10 percent owner | 5430715 11.9441% | $0.63 | 43 | 0 | <0.0001% |
| Strahlman Ellen R | director | 75113 0.1702% | $0.63 | 4 | 0 | +17.3% |
| Rowe Michael M | Chief Executive Officer | 32927 0.0746% | $0.63 | 10 | 0 | <0.0001% |
| Yoshida Shuhei | 1718566 3.895% | $0.63 | 1 | 0 | <0.0001% | |
| Senju Pharmaceutical Co., Ltd. | 10 percent owner | 1718566 3.895% | $0.63 | 1 | 0 | <0.0001% |
| ESHELMAN FREDRIC N | 1273428 2.8861% | $0.63 | 1 | 0 | <0.0001% | |
| Ianchulev Tsontcho | director | 331211 0.7507% | $0.63 | 5 | 5 | <0.0001% |
| MARIO ERNEST | director | 327239 0.7417% | $0.63 | 3 | 0 | +12.05% |
| MATHER CHARLES E IV | director | 77544 0.1757% | $0.63 | 8 | 0 | <0.0001% |
| LEE KENNETH B JR | 42322 0.0959% | $0.63 | 4 | 0 | <0.0001% | |
| LaBelle Curt H | director | 27985 0.0634% | $0.63 | 2 | 0 | <0.0001% |
| GANDOLFO JOHN P | Chief Financial Officer | 8000 0.0181% | $0.63 | 3 | 0 | <0.0001% |
| Kern Bren | Chief Operating Officer | 2500 0.0057% | $0.63 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| The Vanguard Group | $1.77M | 3.32 | 1.79M | +25.25% | +$355,870.86 | <0.0001 | |
| BlackRock | $1.55M | 2.92 | 1.58M | -3.62% | -$58,346.47 | <0.0001 | |
| Cowen Group | $816,261.00 | 1.54 | 827,851 | New | +$816,261.00 | 0.03 | |
| Geode Capital Management | $683,715.00 | 1.29 | 693,343 | +8.49% | +$53,519.35 | <0.0001 | |
| State Street | $512,012.00 | 0.96 | 519,282 | +6.37% | +$30,664.60 | <0.0001 | |
| Northern Trust | $257,423.00 | 0.49 | 261,078 | +3.09% | +$7,718.41 | <0.0001 | |
| Nuveen | $240,399.00 | 0.45 | 243,812 | +21.82% | +$43,057.70 | <0.0001 | |
| Morgan Stanley | $144,165.00 | 0.27 | 146,212 | +42.8% | +$43,206.51 | <0.0001 | |
| Bank of America | $121,963.00 | 0.23 | 123,694 | -8.35% | -$11,116.23 | <0.0001 | |
| Charles Schwab | $74,873.00 | 0.14 | 75,936 | 0% | +$0 | <0.0001 | |
| BNY Mellon | $73,611.00 | 0.14 | 74,656 | -1.85% | -$1,387.31 | <0.0001 | |
| Millennium Management LLC | $71,222.00 | 0.13 | 72,233 | -42.59% | -$52,826.13 | <0.0001 | |
| Xtx Topco Ltd | $64,356.00 | 0.12 | 65,270 | +162.96% | +$39,882.58 | <0.01 | |
| UBS | $44,679.00 | 0.08 | 45,313 | +9.28% | +$3,793.17 | <0.0001 | |
| SEI Investments Company | $43,058.00 | 0.08 | 43,669 | New | +$43,058.00 | <0.0001 | |
| New York State Common Retirement Fund | $40,000.00 | 0.08 | 40,710 | -0.19% | -$75.66 | <0.0001 | |
| Nations Financial Group Inc Ia Adv | $40,327.00 | 0.08 | 40,900 | +0.99% | +$394.40 | <0.01 | |
| Deutsche Bank | $32,533.00 | 0.06 | 32,862 | 0% | +$0 | <0.0001 | |
| Atria Wealth Solutions Inc | $32,538.00 | 0.06 | 33,000 | +17.86% | +$4,930.00 | <0.0001 | |
| Cambridge Investment Research Advisors Inc | $33,000.00 | 0.06 | 33,110 | New | +$33,000.00 | <0.0001 | |
| Susquehanna International Group | $28,452.00 | 0.05 | 28,856 | -67.88% | -$60,133.15 | <0.0001 | |
| RhumbLine Advisers | $26,519.00 | 0.05 | 26,905 | -0.4% | -$107.44 | <0.0001 | |
| Simplex Trading Llc | $24,000.00 | 0.05 | 25,258 | +371.85% | +$18,913.61 | <0.01 | |
| Barclays | $22,000.00 | 0.04 | 22,307 | -46.1% | -$18,820.37 | <0.0001 | |
| Virtu Financial Llc | $21,000.00 | 0.04 | 21,230 | +67.15% | +$8,436.60 | <0.01 | |
| Goldman Sachs | $17,514.00 | 0.03 | 17,763 | -19.04% | -$4,118.45 | <0.0001 | |
| Tower Research Capital | $16,978.00 | 0.03 | 17,219 | +196.73% | +$11,256.22 | <0.0001 | |
| Wells Fargo | $15,139.00 | 0.03 | 15,354 | +11.48% | +$1,558.86 | <0.0001 | |
| American International Group | $15,229.00 | 0.03 | 15,445 | +3.28% | +$484.13 | <0.0001 | |
| Integrated Wealth Concepts Llc | $12,493.00 | 0.02 | 12,670 | 0% | +$0 | <0.0001 | |
| JPMorgan Chase | $12,684.00 | 0.02 | 12,864 | -28.66% | -$5,094.70 | <0.0001 | |
| Cresset Asset Management Llc | $12,325.00 | 0.02 | 12,500 | 0% | +$0 | <0.0001 | |
| Invesco | $12,070.00 | 0.02 | 12,242 | -0.97% | -$118.31 | <0.0001 | |
| Oak Family Advisors Llc | $11,106.00 | 0.02 | 11,264 | 0% | +$0 | <0.01 | |
| LINSCO PRIVATE LEDGER CORP | $11,354.00 | 0.02 | 11,515 | New | +$11,354.00 | <0.0001 | |
| T. Rowe Price | $11,000.00 | 0.02 | 10,712 | New | +$11,000.00 | <0.0001 | |
| CAPTRUST | $9,926.00 | 0.02 | 10,067 | -1.74% | -$175.51 | <0.0001 | |
| Citigroup | $5,256.00 | 0.01 | 5,330 | -2.75% | -$148.90 | <0.0001 | |
| Fidelity Investments | $4,834.00 | 0.01 | 4,903 | -57.77% | -$6,612.61 | <0.0001 | |
| Capital Advisors Ltd Llc | $4,000.00 | 0.01 | 3,616 | New | +$4,000.00 | <0.01 | |
| Royal Bank of Canada | $4,000.00 | 0.01 | 3,647 | -70.37% | -$9,498.22 | <0.0001 | |
| CalSTRS | $3,509.00 | 0.01 | 3,559 | -28.13% | -$1,373.43 | <0.0001 | |
| Legal & General | $3,326.00 | 0.01 | 3,373 | 0% | +$0 | <0.0001 | |
| Advisor Group Holdings Inc | $1,980.00 | <0.01 | 2,000 | New | +$1,980.00 | <0.0001 | |
| Ameritas Investment Partners Inc | $2,265.00 | <0.01 | 2,297 | 0% | +$0 | <0.0001 | |
| Amalgamated Bank | $1,000.00 | <0.01 | 938 | -76.19% | -$3,199.36 | <0.0001 | |
| Citadel Advisors LLC | $1,251.00 | <0.01 | 1,268 | -98.82% | -$104,792.96 | <0.0001 | |
| CWM LLC | $0 | <0.01 | 1 | New | +$0 | <0.0001 | |
| Russell Investments Group Ltd | $60.00 | <0.01 | 61 | 0% | +$0 | <0.0001 | |
| Nelson Van Denburg & Campbell Wealth Management Group LLC | $4.00 | <0.01 | 5 | New | +$4.00 | <0.0001 |